Encefalopatía asociada a Valproato
Valproate can be associated to hyperammonemic encephalopathy, characterized by fluctuating sudden-onset alterations of sensorium, focal symptoms and an increase in the frequency of seizures. We report a 78 year-old female using valproate 1,000 mg/ day for 10 months for the treatment to tonic-clonic...
Guardado en:
Autores principales: | Young,Pablo, Finn,Bárbara C, Álvarez,Florencia, Bruetman,Julio E, Trimarchi,Hernán |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2007
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001100011 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Shunt porto-sistémico congénito en hígado no cirrótico como causante de síndrome confusional agudo reiterado: Report of one case
por: Carrascosa-García,Sara, et al.
Publicado: (2016) -
Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
por: Fumika Azuma, et al.
Publicado: (2021) -
Systemic and clinical treatment of gingival hyperplasia associated with use of anticonvulsant
por: Feijó Miguelis,Tiago Martins, et al.
Publicado: (2019) -
The Prophylactic Effects of Folic Acid and Vitamin E against Valproic Acid During Fetal Thymus Development: an Ultrastructural Study
por: Pamukcu Baran,Ozlem, et al.
Publicado: (2011) -
The Alterations of Microvasculature, Tyrosine Phosphorylation, and Lipid Peroxidation in Kidney of Rats Treated with Valproic Acid
por: Maneenin,Chanwit, et al.
Publicado: (2019)